"There's no clear evidence that there's a substantial numeric risk of bladder cancer in patients taking Actos for diabetes." states American Diabetes Association. European Medicines Agency doesn't agree...

Takeda's Actos Pill Needs New Cancer-Risk Warning, Agency Says

July 22 (Bloomberg) -- Takeda Pharmaceutical Co.'s Actos diabetes drug may be kept on the market with new warnings, the European Medicines Agency said after reviewing research showing the drug carried a slightly increased risk of bladder cancer.

Go to: Diabetes Drug May Cause Bladder Cancer to read the article.